BML 5.01 Decreased By ▼ -0.05 (-0.99%)
BOP 13.06 Increased By ▲ 0.06 (0.46%)
CNERGY 7.10 Decreased By ▼ -0.02 (-0.28%)
CPHL 87.49 Increased By ▲ 1.42 (1.65%)
DCL 14.32 Decreased By ▼ -0.35 (-2.39%)
DGKC 171.00 Increased By ▲ 2.19 (1.3%)
FCCL 46.65 Increased By ▲ 0.48 (1.04%)
FFL 15.90 Decreased By ▼ -0.02 (-0.13%)
GCIL 26.75 Decreased By ▼ -0.51 (-1.87%)
HUBC 144.64 Increased By ▲ 2.73 (1.92%)
KEL 5.07 Decreased By ▼ -0.05 (-0.98%)
KOSM 6.68 Decreased By ▼ -0.21 (-3.05%)
LOTCHEM 20.61 Decreased By ▼ -0.39 (-1.86%)
MLCF 85.10 Increased By ▲ 1.03 (1.23%)
NBP 122.30 Decreased By ▼ -0.08 (-0.07%)
PAEL 43.42 Increased By ▲ 1.24 (2.94%)
PIAHCLA 22.30 Increased By ▲ 0.34 (1.55%)
PIBTL 9.00 Increased By ▲ 0.01 (0.11%)
POWER 14.01 Decreased By ▼ -0.08 (-0.57%)
PPL 170.00 Increased By ▲ 0.05 (0.03%)
PREMA 43.45 Decreased By ▼ -0.32 (-0.73%)
PRL 33.15 Increased By ▲ 0.28 (0.85%)
PTC 24.15 Decreased By ▼ -0.44 (-1.79%)
SNGP 119.25 Decreased By ▼ -0.05 (-0.04%)
SSGC 45.69 Increased By ▲ 0.52 (1.15%)
TELE 8.13 Decreased By ▼ -0.04 (-0.49%)
TPLP 10.47 Increased By ▲ 0.14 (1.36%)
TREET 23.98 Decreased By ▼ -0.17 (-0.7%)
TRG 57.90 Decreased By ▼ -0.95 (-1.61%)
WTL 1.51 Decreased By ▼ -0.04 (-2.58%)
BR100 13,648 Increased By 68.9 (0.51%)
BR30 39,863 Increased By 196.5 (0.5%)
KSE100 134,300 Increased By 517.4 (0.39%)
KSE30 40,814 Increased By 132.5 (0.33%)
Pakistan

Interior Minister Ijaz Shah gets first dose of COVID-19 trial vaccine

  • UHS Vice-Chancellor Prof Javed Akram says the minister’s staff members were also administered the trial vaccine
  • China had supplied the medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement
Published December 7, 2020

(Karachi) Federal Interior Minister Ijaz Shah has been administered trial vaccine of COVID-19 from China at the University of Health Sciences (UHS) Lahore, local media reported on Monday.

“Interior Minister Ijaz Shah was administered the vaccine, which has been in phase three of clinical trials,” UHS Vice-Chancellor Prof Dr Javed Akram said.

“The minister’s staff members were also administered the trial vaccine,” Prof Akram added.

Earlier, Pakistan began final-phase testing of a Chinese-made vaccine against novel coronavirus, the first ever clinical trial of its kind in the South Asian nation.

China had supplied the COVID-19 medication, developed by Chinese biotech CanSinoBio in partnership with the Beijing Institute of Biotechnology, to Islamabad as part of a trial agreement.

So far, the trial vaccine has seen a positive public response, raising the hope that the effort would meet its target. The specific vaccine has already established its safety and efficacy in the previous trials held in China with no serious adverse effects.

It’s now being tested on a wider population in Russia, Mexico, Chile, Argentina, Saudi Arabia and Pakistan; the country has been allocated 8,000 recruits out of a total of 40,000 and is currently conducting the trial at five centres in Islamabad, Lahore and Karachi.

Comments

Comments are closed.